FDA continues prowl for COVID-19 product claims with warning letter to 8th CBD company

Since the beginning of March, federal food and drug regulators have issued warning letters to 64 companies for selling products under claims that they will prevent, treat, mitigate diagnose or cure COVID-19, including eight to CBD companies.

FDA continues prowl for COVID-19 product claims with warning letter to 8th CBD company is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs